GlassScriptPhysician profile
Maureen L Caldwell
NPI 1568464634
$3,399.51
in general payments reported to CMS, 2019-2025
21 companies · $548 in 2025
The $548 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $664 · 2020: $555 · 2021: $532 · 2022: $387 · 2023: $546 · 2024: $169 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,262.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,562.97 | 2020-2025 | Puraply, Affinity, Cygnus Dual |
| Crossroads Extremity Systems, LLC | $333.94 | 2019-2020 | |
| Smith+Nephew, INC. | $246.06 | 2019-2021 | |
| Nevro Corp. | $228.97 | 2022-2023 | Senza |
| Musculoskeletal Transplant Foundation INC. | $181.65 | 2020-2021 | |
| Stryker Corporation | $177.18 | 2022 | |
| Melinta Therapeutics, LLC | $99.27 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $86.57 | 2019 | |
| Medline Industries LP | $83.72 | 2021 | |
| Wright Medical Technology, INC. | $64.67 | 2019 | |
| Integra Lifesciences Corporation | $53.84 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Zimmer Biomet Holdings, INC. | $43.47 | 2023 | Tapestry |
| Medtronic, INC. | $41.40 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Amniox Medical, INC. | $39.12 | 2020 | |
| Paratek Pharmaceuticals, INC. | $34.52 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $34.50 | 2019-2020 | |
| Heron Therapeutics, INC. | $22.04 | 2021 | |
| Kci USA, INC. | $20.20 | 2020 | |
| Kerecis Limited | $15.96 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Horizon Therapeutics Plc | $15.94 | 2023 | Krystexxa |
| Merck Sharp & Dohme LLC | $13.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Caldwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.